Chemotherapy

On the Cytogenetic Criteria of Rational Tumor Chemotherapy.- Life Prolongation of Mice Bearing Syngeneic Tumor, Leukemia P388 with the Streptococcal Preparation, OK-432 and Its Mechanism of Action.- Breakdown of Non-Immune Metastasis Resistance after Cytostatic Drugs.- Prevention of Lymphoma Growth in Mice by a Covalent Drug-Carrier-Antibody Complex.- Effects of Anti-DNA and Anti-RNA Antibodies Bound to Melphalan and Methotrexate on C3H Mammary Adenocarcinoma and L1210 Leukaemia.- Immunosuppressive Effects of Some Organic Compounds with Anti-Inflammatory Activity.- Differential Immunosuppressive Effects of Anticancer Agents on Lymphoid Subpopulations.- Experiments and Theoretical Considerations on Synchronisation of L1210 Ascites Tumour Cells and Crypt Epithelia of the Mouse with Vincristine.- Theoretical Bases for Designing Combination Therapy with Dibromodulcitol (DBD).- Tilorone HYdrochloride: Its Pharmacokinetic Parameters and Its Pharmacodynamic Effects.- Pharmacokinetics of Futraful (FT-207) for Clinical Application.- Effects of Cytotoxic Drugs and/or Corticosteroids on Peripheral Leukocytes.- The Effectiveness of Sequential Therapy Schedules with Adriamycin and Cyclophosphamide in the P388 Leukemia Model.- Antitumor Activity of Mimosine and Mimosine HYdrochloride Against B16 Melanoma in BDF1 Mice.- A New Multipeptide Antitumour Drug.- Metabolism of the Tumour-Inhibitory 3,3-Dimethyl-1-Phenyl-Triazene and Its 4-Chlorophenyl Analogue.- Antitumour Activity of Benzofuroxan Derivatives.- Antitumour Activity of Tetrazolopyridazines and Tetrazolophthalazines.- Antineoplastic Effect of Compound 9777-VUFB in Animals with Experimental Tumours; Its Interaction with Some Cutostatics.- Effects of GP 48 989 Alone and in Combination with Hormones and Chemotherapeutic Agents onDMBA-Induced Mammary Carcinomata II.- R 17934: A New Synthetic Anticancer Drug Interfering with Microtubules.- Antitumour Activity of Carminomycin.- Variamycin, a New Antitumour Antibiotic.- Inhibition by Caffeine of Post-Replication DNA Repair in Hamster Cells Treated with cis platinum (II) Diammine Dichloride.- The Role of Nuclear Proteins in the Chemotherapeutic Effect of Dibromodulcitol (DBD).- The Effect of Dibromodulcitol on the Replication of DNA in Yoshida Sarcoma Cells.- Clinical Cancer Chemotherapy with Drugs Aimed at Gene Regulators.- Characterization of the Bleomycin Action on DNA.- Antitumour Antibiotic Carminomycin: Mechanism of Action.- Effect of Combined Chemotherapy with Lysosome Labilizers and Mitomycin-C.- Optimal Conditions for Tumor Chemotherapy Chosen on the Basis of Changes in the Lipid Antioxidant Activity.- An Antitemplate Approach to Develop Selective Inhibitors of Oncornaviral Reverse-Transcriptase.- Experimental Approach to Increase the Effects of Cancer Chemotherapy in Tumor-Bearing Rats Pretreated with an Inducer on Microsomal Drug-Metabolizing Enzyme (cytochrome p-450).- Effect of the Drug-Metabolizing Enzyme Inducers on the Cytostatic Activity of Dibromodulcitol.- Studies of N-Methyl-N-Nitrosourea-C14O Pharmacokinetics in Mice with Hepatoma 22A.- Collateral Sensitivity Between an Alkylating Agent and Halogenated Methotrexate.- Meso-1,2 bis-(3,5-Dioxopiperazine-1-y1)-1,2-Dimethyl-ethane (ICRF 193): A Potent Antitumour Analogue of ICRF 159.- New Derivatives of Nitrosourea with a High Therapeutic Index for Oncostatism and Immunosuppression.- Effect on L1210 Leukaemia, on Antibody Forming Cells, and on Macrophage cytotoxicity of Ellipticine and Three Derivatives.- Antitumor Activity of Daunorubicin Derivatives.- New Antitumour Analogues of Cytosine Arabinoside and the Effect Against Mouse Leukemia L1210.- Exceptional Responses to Chemotherapy and/or Hormonotherapy of Cases with Generalized Cancer.- Clinical Considerations in Myelomatosis.- Chronic Gastritis, Atypical Epithelia in Biopsies and Therapeutic Consequences.- Clinical Studies on Changes in Serum Glycoproteins in Cancer Chemotherapy.- Double-Blind Trial with Levamisole in Resectable Lung Cancer.- Carcino-Embryonic Antigen Determinations and Chemotherapy in Cancer Patients.- Aspects of Chemo-Immunotherapy in a Controlled Clinical Study for the Treatment of Bronchogenic Cancer.- Pulse-Cytophotometric Monitoring of the Intensive Chemotherapy of Acute Leukaemia.- Treatment of Adenocarcinoma of the Ovary with Combined Immunotherapy and Chemotherapy.- Clinical and Experimental Studies on Immunochemotherapy Using OK-432, a New Streptococcal Preparation.- Phase I and Phase II Studies in the Treatment of Cancer Patients by Radiotherapy, Chemotherapy and Methanol Extraction Residue of an Anti-Tuberculosis Vaccine (MER).- Additional Therapy with Trenimon in Treatment of Carcinoma of the Uterine Cervix.- Interferences of Radiotherapy and Chemotherapy on the Binding of 3H-17?-oestradiol with Its Specific Receptors.- Mechanism of Antitumor Action of Hemolytic Streptococcal Preparation OK-432 (NSC-B116209) for Malignant Pleural or Peritoneal Effusion by Intrathoracal and Intraperitoneal Injection.- The Significance of Reduction Surgery in the Treatment of Advanced Cancer Patients.- Intermittent Long Term Polychemotherapy as an Adjuvant to Surgery of Bronchogenic Carcinoma.- Polychemotherapy for Advanced Lung Carcinoma: Clinical Results and Further Consequences.- Chemotherapy in Conservative Treatment of Lung Cancer Patients.- Effective Chemotherapy for BronchialCarcinoma.- MUltidisciplinary Curative Assault on Disseminated Carcinoma of the Breast.- Potentiation of Drugs Using Sequential Chemotherapy Against Disseminated Breast, Bronchial, and Central Nervous System Solid Tumors.- Animal and Human Studies with Oral Mitomycin C(6): A Preliminary Report.- Chemohormonal Therapy of Breast Cancer — A Pilot Phase I-II Study.- The Results of Cleomycin Treatment in 90 Patients with Malignant Disease.- Cis-Platinum Diaminodichloride in the Treatment of Squamous Cell Carcinoma and Other Malignant Diseases.- Anhydro-Arabinosyl-Fluorocytosine HYdrochloride: A Phase I Study.- Ifosfamide in the Treatment of Lung Cancer and Metastases of Solid Malignant Tumours.- Preclinical and Phase-I Studies of Ifosfamide for Its Massive Dose Cumulation Schedule.- Clinical Pharmacological Studies with Formyl-Leurosin in Malignant Diseases.- Clinical Investigations with F-Leurosine.- Clinical Investigations of Dibramodulcitol in the Treatment of Malignant Diseases.- Oral Estracyt® (Estramustine phosphate) in the Treatment of Advanced Carcinoma of the Prostate.- Treatment of Prostatic Carcinoma with Estracyt® (Estramustine phosphate).- Clinical Use of DDMP in Cancer Chemotherapy.- Combination of Anticoagulants and Antineoplastic Drugs in Cancer Chemotherapy.- Adriamycin Cardiotoxicity in Man: Effect of Pretreatment with Beta-Methyldigoxin. A Poligraphic Study.- Combination of Adriamycin and Bleomycin in the Treatment of Advanced Cervical Cancer.- Treatment of Chemotherap,y Resistant Nonseminomatous Testicular Tumors with DDP (NSC-119875).- Combination Chemotherapy of Advanced Hodgkin’s Disease with Adriamycin, DTIC, CCNU, and Bleomycin.- Proteolytic Enzymes in the Treatment of Malignant Pleural Effusions and Solid Metastases.- Intra-ArterialChemotherapy of Head and Neck Squamous Cell Carcinoma.- Chemotherapy of Glioblastoma Multiforme: A Statistical Analysis of Its Effect.- 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in the Treatment of Primary Central Nervous System Tumors.- BCNU and CCNU Chemotherapy of Tumours of the Central Nervous System.- Combination Chemotherapy and CCNU Treatment of Glioblastoma: A Comparative Trial.- Combination of Adriamycine, VM26, Cyclophosphamide and Prednisone (AVmCP) in Chemotherapy of Lympho and Reticulum Cell Sarcoma (Stages and Topographic Forms III and IV).- Comparison of PDN + VCR°; PDN + VCR° ? ADMx; PDN + VCR° ? ADMx ? CARx; and PDN + VCR + ASp° in Induction of First Remission of Acute LYmPhoid Leukemia.- Clinical Evaluation of Peptichemio in Some Hemoblastoses and Solid Tumours.- Chemotherapeutic Management of Non-Hodgkin’s Lymphoma: Comparative Study of Various Combinations.- Chemotherapy for Gastric and Colorectal Carcinoma by Intra-aortic Infusion.- Effect of Adjuvant Chemotherapy with Mitomycin C on the Recurrence of Gastric Cancer after Radical Surgery.- Long-Term Cancer Chemotherapy for Stage III to IV Gastric Cancer Following Non-Curative Resection.- Chemotherapy for Advanced Ovarian Malignancy.- Changes in Clinical and Histological Patterns Observed in Patients with Advanced Carcinoma of the Ovary Treated with Progesterone.- List of Contributors.